BZI-WIIM

180 Life Sciences (NASDAQ:ATNF) shares are trading higher after Maxim Group initiated coverage on the stock with a Buy rating and $11 price target. 180 Life Sciences' stock is trading up 16.05% to a price of $6.58. The stock's volume is currently 5.03 million, which is roughly 731...

Molecular Data (NASDAQ:MKD) shares are trading lower after the company priced an offering of units at $0.38 per unit. Molecular Data is currently down 22.3% to a price of $0.33. Wednesday the stock has been traded at a volume of 15.02 million, about 420.37% of its recent 30-day volume average...

DAVIDsTEA (NASDAQ:DTEA) shares are trading lower after the company reported Q2 EPS results were down year over year. DAVIDsTEA is currently down 18.9% to a price of $2.68. The stock's volume is currently 1.09 million, which is roughly 1060.29% of its recent 30-day volume average of 102.78...

Nuwellis (NASDAQ:NUWE) shares are trading lower after the company announced it priced a 3,483,120 share common stock offering at $2.50 per share. Nuwellis' stock has been falling Wednesday, down 28.46% to a price of $2.64. Wednesday the stock has been traded at a volume of 1.18...

SoFi Technologies (NASDAQ:SOFI) shares are trading higher after Mizuho initiated coverage on the stock with a Buy rating and announced a $28 price target. SoFi Technologies is currently up 5.48% to a price of $15.29. The stock's volume is currently 21.41 million, which is roughly 106.19%...

Steel Dynamics (NASDAQ:STLD) shares are trading higher after the company issued Q3 EPS guidance above analyst estimates. Steel Dynamics' stock is trading up 3.91% to a price of $64.39. The stock's current volume for the day is 1.52 million, which is approximately 80.43% of its...

KalVista Pharmaceuticals (NASDAQ:KALV) shares are trading lower after the FDA notified the company that it has placed a clinical hold on its Phase 2 clinical trial of KVD824. KalVista Pharmaceuticals' stock has been rising Wednesday, up 0.86% to a price of $19.27. The stock's...

Sage Therapeutics (NASDAQ:SAGE) shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington's disease. Sage Therapeutics is currently up 3.42% to a price of $45.09. Wednesday the stock has been traded at a volume of...

Citrix Systems (NASDAQ:CTXS) shares are trading higher following a Bloomberg report titled 'Citrix Explores Potential Sale After 2021 Stock Tumble.' Citrix Systems' stock has been rising Wednesday, up 3.04% to a price of $112.91. The stock's volume is currently 1.71...

Matinas BioPharma Hldgs (AMEX:MTNB) shares are trading higher on continued upward momentum after the company yesterday announced data in the ongoing EnACT trial of MAT2203 for treatment of cryptococcal meningitis. Matinas BioPharma's stock is currently up 12.38% to a price of $1.18. The...

Herbalife Nutrition (NYSE:HLF) shares are trading lower after the company reported it revised its third-quarter and full-year 2021 guidance. Herbalife Nutrition stock has been falling Tuesday, down 21.11% to a price of $42.79. The stock's volume is currently 8.58 million, which is...

Virpax Pharmaceuticals (NASDAQ:VRPX) shares are trading lower after the company priced a 6.67 million share common stock offering at $6 per share. Virpax Pharmaceuticals' is currently down 37.64% to a price of $6.07. The stock's volume is currently 3.36 million, which is roughly 37.66...

Nanoviricides (AMEX:NNVC) shares are trading higher after the company announced it completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc. Nanoviricides' stock is currently up 16.22% to a price of $4.73. The...

CYREN's (NASDAQ:CYRN) shares are trading higher on abnormally-high volume. The company announced it teamed with TD SYNNEX to distribute next gen anti-phishing solution in North America. The stock is also seeing retail investor interest. CYREN's stock is trading up 26.51% to a price of...

10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target. 10x Genomics' stock is currently down 7.53% to a price of $156.27. Tuesday the stock has been traded at a volume of 889.55 thousand, about...